MedWellAI Inc. MWAI
—
0.34
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow MWAI
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.70 | 2.87 | 4.58 | 3.45 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 6.70 | |
P/Operating CF |
(324.32) | (36.97) | (18.47) | (18.88) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
6.37 | 8.98 | 14.15 | 3.33 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(24.54) | (15.30) | (12.60) | (2.33) | |
EV/FCF |
(34.39) | (12.57) | (10.68) | 6.46 | |
Quick Ratio |
0.02 | 0.02 | 0.03 | 0.13 | |
Current Ratio |
0.02 | 0.02 | 0.03 | 0.14 | |
Net Debt/EBITDA |
(29.03) | (23.97) | (19.76) | 0.36 | |
Debt/Assets |
2,019.89% | 1,410.28% | 1,182.03% | 0.00% | |
Debt/Equity |
(0.86) | (0.89) | (0.92) | 0.00 | |
Asset Turnover |
1.29 | 0.67 | 0.35 | 0.25 | |
Operating CF/Net income |
0.03 | 0.30 | 0.26 | 0.10 | |
Capex/Depreciation |
(0.94) | 0.00 | (0.88) | (38.61) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
58.91% | 74.83% | 430.59% | 312.57% | |
Intangible Assets out of Total Assets |
0.10 | 0.09 | 0.08 | 0.06 | |
Share Based Compensation of Revenue |
1.33% | 8.97% | 51.30% | 29.04% | |
Graham Net Nets |
(3.16) | (2.42) | (2.34) | (1.33) | |
Graham Number |
3.14 | 3.33 | 3.60 | 4.05 | |
Earnings Yield |
(93.21%) | (84.70%) | (98.73%) | (178.75%) | |
Free Cash Flow Yield |
(10.92%) | (24.91%) | (28.96%) | 14.93% | |
Revenue per Share |
0.10 | 0.09 | 0.02 | 0.03 | |
Operating CF per Share |
0.00 | (0.01) | (0.03) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.04) | |
Free Cash Flow per Share |
0.00 | (0.01) | (0.03) | (0.06) | |
Cash per Share |
0.02 | 0.02 | 0.04 | 0.07 | |
Shareholders Equity per Share |
(1.21) | (1.16) | (1.14) | (0.41) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(1.21) | (1.16) | (1.14) | (0.41) | |
Free Cash Flow |
(0.02) | (0.08) | (0.18) | (0.32) | |
Working Capital |
(7.61) | (7.51) | (7.29) | (2.64) | |
Capital Expenditures |
(0.01) | — | (0.01) | (0.21) | |
Net Current Asset Value |
(7.68) | (7.59) | (7.37) | (2.72) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.08 | 1.23 | |
Net Profit Margin |
(38.82%) | (52.43%) | (678.36%) | (666.23%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.00 | — | — | 0.01 | |
Average Payables |
0.11 | 0.52 | 0.54 | 0.13 | |
Average Assets |
1.11 | 1.64 | 1.99 | 2.37 | |
Average Common Equity |
(6.43) | (6.25) | (5.79) | (5.16) |
Columns are period end dates